Single Lung Transplant Surgery Recovery, Weeks 1–4: ICU, Inpatient, and Early Post-Discharge Recovery
Weeks 1–4 after single lung transplant surgery make up phase 1 of 4 in a typical 16-week recovery: ICU, Inpatient, and Early Post-Discharge Recovery. Your own surgeon's instructions always come first.
Goals for weeks 1–4
- The transplanted lung is denervated — the nerve supply that normally coordinates cough, airway tone, and mucociliary clearance below the bronchial anastomosis has been severed. This is not a complication; it is an inevitable consequence of the transplant procedure, and it will not recover. The practical meaning of denervation is that you cannot rely on your transplanted lung to warn you that something is wrong the way your native lungs would. An infection brewing in the transplanted lung may not trigger a cough. Aspirated food or liquid may not provoke the reflex clearing response that would normally protect you. This is why home spirometry, regular surveillance bronchoscopy, and aggressive pulmonary hygiene are not optional — they are the substitute for the protective reflexes your transplanted lung has lost.
- Your immunosuppressive regimen consists of three medications working through different mechanisms to prevent your immune system from destroying the transplanted lung. The standard triple therapy includes tacrolimus (a calcineurin inhibitor that is the backbone of transplant immunosuppression), mycophenolate mofetil (an antimetabolite that suppresses lymphocyte proliferation), and prednisone (a corticosteroid that broadly dampens the immune response). Many centers use induction therapy with basiliximab or antithymocyte globulin at the time of transplant to provide intense immunosuppression while oral medications reach therapeutic levels.
- Tacrolimus requires trough level monitoring — a blood draw taken 12 hours after your last dose, typically before your morning dose. Levels are checked frequently in the first weeks, often daily during the inpatient stay and then two to three times weekly after discharge. The therapeutic window is narrow: too little and you risk rejection; too much and you risk nephrotoxicity, neurotoxicity (tremor, headache, and in severe cases posterior reversible encephalopathy syndrome), hypertension, and diabetes. Learning to take tacrolimus at exactly the same times every day, consistently with or without food as directed, is essential. The consequences of non-adherence are severe. Acute cellular rejection is most common in the first six months, and even a few missed doses during this period can trigger an episode that permanently damages the graft.
- Acute cellular rejection is most common in the first six months after lung transplant and is monitored through two complementary systems. Surveillance transbronchial biopsies are the gold standard — protocol bronchoscopies are typically performed at approximately 1 month, 3 months, 6 months, and 12 months after transplant, though many centers perform additional biopsies if there is clinical suspicion. Each bronchoscopy involves passing a flexible bronchoscope through the mouth or nose into the transplanted lung, where small tissue samples (biopsies) are taken from the airway wall and lung parenchyma. Bronchoalveolar lavage is performed simultaneously to evaluate for infection. The procedure is done under sedation and takes approximately 30 to 45 minutes. It is uncomfortable but not painful, and most patients tolerate it well after the first experience.
- Home spirometry is the second surveillance system and in many ways the more important one for day-to-day management. You will be provided with a portable handheld spirometer and instructed to perform daily measurements of your forced expiratory volume in one second (FEV1) and forced vital capacity (FVC). These values should be recorded and reported to your transplant team according to their protocol — many centers use smartphone applications that transmit data directly. The critical threshold to understand is this: a sustained decline in FEV1 of more than 10 percent from your established personal best baseline triggers urgent evaluation. This decline could represent acute rejection, infection, airway anastomotic stricture, or the early stages of chronic lung allograft dysfunction. It may not cause symptoms that you notice, which is precisely why daily spirometry is so important. Your transplanted lung's denervated airways may not generate the dyspnea or cough that would normally alert you to trouble.
- Infection is the leading cause of death in the first year after lung transplant, and the transplanted lung's direct exposure to the environment makes it uniquely vulnerable among transplanted organs. Your prophylactic medication regimen addresses the three major categories of opportunistic infection. Valganciclovir prevents cytomegalovirus (CMV) reactivation — CMV can directly damage the transplanted lung and has been associated with accelerated development of chronic rejection. The duration of valganciclovir prophylaxis depends on the CMV serostatus of donor and recipient, with donor-positive/recipient-negative (D+/R-) patients at highest risk and receiving the longest prophylaxis, typically 12 months. Trimethoprim-sulfamethoxazole (TMP-SMX) prevents Pneumocystis jirovecii pneumonia (PJP), which can be fatal in immunosuppressed patients. Many lung transplant centers continue PJP prophylaxis indefinitely. Antifungal prophylaxis targets Aspergillus species, which can colonize the bronchial anastomosis and cause invasive disease. Inhaled amphotericin, itraconazole, or voriconazole are used depending on center protocol and patient risk factors.
- Behavioral infection prevention measures are the same rigorous precautions required after any solid organ transplant. Frequent thorough hand washing. Avoidance of sick contacts. Avoidance of crowds and enclosed public spaces in the first three months. Food safety: no raw or undercooked meat, fish, or eggs; no unpasteurized dairy; thorough produce washing. Avoidance of gardening without gloves, cat litter, bird droppings, and stagnant water. These precautions are most stringent early and are gradually relaxed, though a baseline level of vigilance remains permanent.
- Because your transplanted lung cannot cough effectively on its own below the anastomosis, active pulmonary hygiene is essential. Incentive spirometry should be used frequently — 10 repetitions every one to two hours while awake during the first two weeks. Directed cough techniques should be practiced: deep inspiration, brief hold, and a forceful cough while splinting the thoracotomy incision with a pillow. Some patients benefit from airway clearance devices such as oscillating positive expiratory pressure (PEP) devices or flutter valves, which help mobilize secretions from the small airways into larger airways where they can be cleared. Nebulized hypertonic saline may be used to improve secretion clearance.
- Early mobilization begins in the ICU. Sitting in a chair on the first postoperative day, standing and taking steps as soon as hemodynamically stable, and progressing to hallway walking during the inpatient stay. The goal during Phase 1 is not fitness but functional independence — the ability to perform basic activities of daily living, walk on flat surfaces, and manage stairs. Formal outpatient pulmonary rehabilitation begins after hospital discharge, typically within the first two to four weeks, and is a critical component of lung transplant recovery. Patients who were enrolled in pulmonary rehabilitation before transplant have a significant advantage because they understand exercise pacing, breathing techniques, and the effort required.
- One or more chest tubes are placed during surgery to drain the pleural space. Output is monitored for volume and character, and tubes are removed when output falls below threshold (typically less than 200 mL per 24 hours) and there is no significant air leak. After discharge, the thoracotomy incision should be kept clean and dry, inspected daily for signs of infection, and not submerged in water until fully healed. The posterolateral thoracotomy incision is large and crosses multiple muscle planes, so wound healing takes several weeks. Some patients experience seroma formation — a collection of fluid beneath the incision — which is usually managed conservatively but should be reported.
- Thoracotomy pain is among the most intense of any surgical incision. The intercostal nerves that run along the ribs are stretched, compressed, or transected during the procedure, and the resulting pain is sharp, position-dependent, and exacerbated by deep breathing and coughing — precisely the activities that are most important for pulmonary hygiene. Effective pain management is therefore not merely a comfort measure but a clinical necessity. Many centers use thoracic epidural catheters or paravertebral nerve blocks during the first 3 to 5 postoperative days, transitioning to oral multimodal analgesia. The oral regimen typically combines scheduled acetaminophen, gabapentin or pregabalin for neuropathic intercostal pain, and opioids with a defined taper. NSAIDs are avoided because renal function must be preserved for safe immunosuppressive management. Patients should understand that some degree of thoracotomy pain persists for weeks to months and that a minority develop chronic post-thoracotomy pain syndrome from intercostal nerve injury.
- Gastroparesis and gastroesophageal reflux are remarkably common after lung transplant, likely related to vagus nerve injury during the procedure and the effects of immunosuppressive medications. This is far more than a comfort issue. Aspiration of gastric contents into the transplanted lung — even microaspiration that occurs silently during sleep — has been convincingly associated with the development of chronic lung allograft dysfunction. Aggressive reflux management with proton pump inhibitors is standard, and some patients require prokinetic agents. Patients should be counseled to elevate the head of bed, avoid eating within 3 hours of lying down, and report new or worsening reflux symptoms promptly. Some centers perform routine esophageal pH monitoring or gastric emptying studies to identify patients at high aspiration risk, and in severe cases, surgical fundoplication may be recommended.
- FEV1 and FVC measurements (home spirometer, recorded and reported)
- Oxygen saturation at rest and with activity
- Temperature (report any fever above 38.0C)
- Sputum: amount, color, consistency (changes may indicate infection)
- Medication adherence confirmation (exact times)
- Pain level and adequacy of analgesia
- Thoracotomy wound inspection (photo for check-in)
- Fluid intake
- Reflux symptoms
- Exercise tolerance (distance walked, exertion level)
- Mood and energy level
What to avoid in weeks 1–4
- No lifting heavier than 5 kg for the first 6 weeks (protects thoracotomy healing)
- No driving until transplant team clearance (typically 6-8 weeks)
- No submersion of wound in water until fully healed
- Strict medication adherence — never miss a dose, never adjust without team guidance
- Infection precautions as outlined above (most intensive in first 3 months)
- No live vaccines (lifelong)
- No NSAIDs (nephrotoxic; acetaminophen only for pain relief)
- No grapefruit or grapefruit juice (alters tacrolimus metabolism)
- No herbal supplements or OTC medications without transplant team approval
- Sun protection lifelong (immunosuppression significantly increases skin cancer risk)
- No smoking or secondhand smoke exposure (absolute — destroys the graft)
Call your care team if, during weeks 1–4:
- Acute dyspnea or new oxygen requirement (rejection, infection, PE, or anastomotic complication)
- FEV1 decline of more than 10% from established baseline on home spirometry
- Fever above 38.5C with rigors, productive cough, or hemodynamic changes
- Hemoptysis (any amount — airway anastomotic concern until proven otherwise)
- Sudden chest pain with respiratory distress (pneumothorax, PE, or pleural complication)
- Signs of stroke: new focal deficit, speech difficulty, facial asymmetry
- Seizure or severe headache with visual changes (tacrolimus toxicity or PRES)
- Signs of sepsis: fever with confusion, tachycardia, hypotension
Weeks 5–8: Pulmonary Rehabilitation and Graft Optimization →
See the whole recovery timeline →
Follow weeks 1–4 in Surgily
Surgily shows each day's exercises for this phase, lets you log how you feel in 30 seconds and share it with your care team, and tells you clearly when to get help.
Get my recovery plan →